Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 10/20 | 0.73 |
| ▸ | MEN1 | O00255 | 7/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6281762 | 0.85 | MEN1 (0.69) | KMT2AMEN1ALDH1A1LMNAUSP2 | |
| SCHEMBL6273823 | 0.85 | KMT2A (1.00) | KMT2AMEN1ALDH1A1LMNAUSP2 | |
| SCHEMBL6274351 | 0.84 | MEN1 (0.80) | KMT2AMEN1ALDH1A1LMNAUSP2 | |
| SCHEMBL6346019 | 0.80 | KMT2A (0.76) | KMT2AMEN1ALDH1A1LMNAUSP2 | |
| SCHEMBL29958944 | 0.79 | KMT2A (0.83) | KMT2AMEN1ALDH1A1LMNAUSP2 | |
| SCHEMBL6279635 | 0.79 | ALDH1A1 (0.65) | KMT2AMEN1ALDH1A1LMNAUSP2 | |
| SCHEMBL6281550 | 0.78 | KMT2A (0.86) | KMT2AMEN1ALDH1A1LMNAUSP2 | |
| SCHEMBL6279510 | 0.78 | KMT2A (0.73) | KMT2AMEN1ALDH1A1LMNAUSP2 | |
| SCHEMBL6280222 | 0.77 | ALDH1A1 (0.74) | KMT2AMEN1ALDH1A1LMNAUSP2 | |
| SCHEMBL6280699 | 0.76 | ALDH1A1 (0.81) | KMT2AMEN1ALDH1A1LMNAUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005115147-A2 | HIV REVERSE TRANSCRIPTASE INHIBITORS | MERCK & CO., INC. (US) | 2005-12-08 | — | — | WO | disclosed |